Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Cash from Financing Activities: 2019-2025

Historic Cash from Financing Activities for Legend Biotech (LEGN) over the last 7 years, with Sep 2025 value amounting to $670,000.

  • Legend Biotech's Cash from Financing Activities fell 84.22% to $670,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $14,000, marking a year-over-year decrease of 99.80%. This contributed to the annual value of $5.7 million for FY2024, which is 99.28% down from last year.
  • Per Legend Biotech's latest filing, its Cash from Financing Activities stood at $670,000 for Q3 2025, which was up 167.68% from -$990,000 recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Cash from Financing Activities registered a high of $790.0 million during Q2 2023, and its lowest value of -$990,000 during Q2 2025.
  • Over the past 3 years, Legend Biotech's median Cash from Financing Activities value was $831,000 (recorded in 2024), while the average stood at $72.5 million.
  • Within the past 5 years, the most significant YoY rise in Legend Biotech's Cash from Financing Activities was 78,200.10% (2023), while the steepest drop was 1,876.00% (2023).
  • Legend Biotech's Cash from Financing Activities (Quarterly) stood at $323.6 million in 2021, then plummeted by 100.24% to -$783,000 in 2022, then soared by 218.14% to $925,000 in 2023, then crashed by 136.00% to -$333,000 in 2024, then crashed by 84.22% to $670,000 in 2025.
  • Its Cash from Financing Activities stands at $670,000 for Q3 2025, versus -$990,000 for Q2 2025 and $667,000 for Q1 2025.